In a curious move today, the U.S. Food and Drug Administration (FDA) named two acting directors to the office of women's health. This morning FDA Commissioner Lester Crawford appointed a man who has spent the majority of his career in the office of veterinary medicine to the position of acting director of the Office of Women's Health. By this afternoon, Dr. Norris Alderson had been replaced with a Ms. Teresa Toigo. Ms. Toigo will replace Dr. Susan Wood, a key women's health expert, who resigned on August 31 in protest of the FDA's handling of the application to make Plan B emergency contraception (EC) available over the counter.
Planned Parenthood Federation of America Interim President Karen Pearl issued these comments on the appointment:
"It appears something funny is going on at the FDA and Planned Parenthood is not laughing. At a time when the FDA's credibility is already in question, these unusual announcements are troubling.
Now the FDA denies the move.
No comments:
Post a Comment